CARNEXIV (U.S. Trademark Serial Number 88219149) is a United States trademark of Lundbeck LLC. The goods and services include: Vaccines; pharmaceutical preparations and substances for the prevention and treatment of disorders and diseases in, generated by or acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of epilepsy and brain disorders and diseases . The correspondent is Alexander Reid of WHITE & CASE LLP.
This trademark was filed on December 06, 2018 as United States Trademark Application Serial Number 88219149. This trademark application is still pending and does not yet have a registration number.
Trademark PTO Status History
July 04, 2022 – ABANDONMENT – NO USE STATEMENT FILED
December 02, 2021 – NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
December 01, 2021 – SOU EXTENSION 5 GRANTED
November 23, 2021 – SOU EXTENSION 5 FILED
December 01, 2021 – CASE ASSIGNED TO INTENT TO USE PARALEGAL
November 23, 2021 – TEAS EXTENSION RECEIVED
November 16, 2021 – TEAS CHANGE OF CORRESPONDENCE RECEIVED
November 16, 2021 – TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
View full trademark status information at USPTO
Ownership History
Lundbeck LLC
Lundbeck LLC
View documents on file at USPTO
File a Trademark or Get Help With Trademark Law
Select IP monitors top trademarks which have been allowed and granted worldwide. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.